NOTICE OF ALLOWANCE - ISSUED
issued
on 12 Mar 2024
Last Applicant/ Owned by
Baarerstrasse 14
ZUG V8 SWITZERLAND
CH
6300
Serial Number
97635380 filed on 17th Oct 2022
Registration Number
N/A
Correspondent Address
Tiffany D. Gehrke
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
"DE&I" AND "DIVERSITY, EQUITY, AND INCLUSION"
CRISPR THERAPEUTICS DE&I IT'S IN OUR DNA. DIVERSITY, EQUITY, AND INCLUSION
Scientific research and development, namely, gene editing for researching and developing human cells and pharmaceuticals; research and development of therapeutics pharmaceuticals using gene editing; pharmaceutical, medical, scientific, and biopharmaceutical research and development; medical laboratory services; scientific laboratory services; custom cell-line engineering services; medical and scie Read More
Classification Information
Class [042]
Computer & Software Services & Scientific Services
Scientific research and development, namely, gene editing for researching and developing human cells and pharmaceuticals; research and development of therapeutics pharmaceuticals using gene editing; pharmaceutical, medical, scientific, and biopharmaceutical research and development; medical laboratory services; scientific laboratory services; custom cell-line engineering services; medical and scientific research in the fields of pharmaceuticals, genetics, genome editing, gene editing, genome engineering, gene modulation, transcriptional regulation, transcriptional modulation, genetic diseases, gene therapy and cell therapy; providing medical research and scientific research information in the fields of pharmaceuticals, genetics, genome editing, gene editing, genome engineering, gene modulation, transcriptional regulation, transcriptional modulation, genetic diseases, gene therapy and cell therapy; scientific research and development services relating to targeting genetic therapies to individuals
Class [041]
Education and Entertainment Services
Education services, namely, providing on-line non-downloadable articles and newsletters in the field of pharmaceuticals, genetics, genome editing, gene editing, genome engineering, gene modulation, transcriptional regulation, transcriptional modulation, genetic diseases, gene therapy and cell therapy
Mark Details
Serial Number
No 97635380
Mark Type
No Service Mark
Attorney Docket Number
No 33324/60066
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Design Code(s)
26.01.29 -
Helixes
Description of Design Search
The mark consists of a double helix to the left of the terms CRISPR THERAPEUTICS DE&I IT'S IN OUR DNA DIVERSITY, EQUITY, AND INCLUSION.
Legal History
| Status Date | Action Taken |
|---|---|
| 12th Mar 2024 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| 16th Jan 2024 | PUBLISHED FOR OPPOSITION |
| 16th Jan 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| 27th Dec 2023 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| 13th Dec 2023 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| 12th Dec 2023 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| 11th Dec 2023 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| 11th Dec 2023 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| 12th Sep 2023 | NON-FINAL ACTION WRITTEN |
| 12th Sep 2023 | NON-FINAL ACTION E-MAILED |